Healthcare News
Outcomes of total knee arthroplasty in people with diabetes: An overview of systematic reviews and meta-analysis
Total knee arthroplasty (TKA) in people with diabetes is associated with increased risks of postoperative complications. This review evaluates how diabetes influences complication rates and overall outcomes following TKA.
Does running ruin your knees? And how old is too old to start?
You've probably heard that running is tough on your knees—and even that it can cause long-term damage. But is this true?
8 Types of Shoulder Surgeries
Common types of shoulder surgeries include rotator cuff repair, total shoulder replacement, and arthroscopy for conditions like frozen shoulder or impingement syndrome. In general, these and other shoulder procedures help treat shoulder injuries by repairing or replacing cartilage, tendons and ligaments, muscles, and joints.
Clinical results of reverse shoulder arthroplasty after failed arthroscopic rotator cuff repair compared to primary cases: a case–control study
Shoulder arthroscopy is a valuable diagnostic tool for painful anatomical shoulder arthroplasty offering some therapeutic opportunities. It has been demonstrated as a sensitive option to diagnose periprosthetic joint infection and is most frequently used for this purpose. Additionally, it offers the possibility of diagnosing some complications after shoulder arthroplasty such as component loosening or rotator cuff failure. As therapeutic options are mostly limited to arthrolysis, and débridement and decompression, most patients will have to face a revision arthroplasty. Nevertheless, diagnostic arthroscopy provides a valuable tool to gain information on the cause of the symptoms to determine further steps of treatment.
XSTEM’s Knee Osteoarthritis Stem Cell Trial: Mid-Study Update, Safety and Positive Efficacy
Xintela has released interim data from its ongoing clinical study evaluating its stem cell product, XSTEM, in patients with knee osteoarthritis. XSTEM is an allogeneic adipose stem cell therapy, consisting of integrin α10β1-selected mesenchymal stem cells. At 18 months post-treatment, the company reports demonstrated safety and positive efficacy, including statistically significant and clinically meaningful improvements in knee pain and knee function.
